RIVERHEAD CAPITAL MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
RIVERHEAD CAPITAL MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$312,000
-12.8%
3,1340.0%0.01%
-7.7%
Q2 2019$358,000
+0.6%
3,134
+10.6%
0.01%
-7.1%
Q1 2019$356,000
-7.5%
2,8340.0%0.01%
-17.6%
Q4 2018$385,000
-50.5%
2,8340.0%0.02%
-39.3%
Q3 2018$778,000
+32.5%
2,8340.0%0.03%
+21.7%
Q2 2018$587,000
+25.4%
2,8340.0%0.02%
+15.0%
Q1 2018$468,000
+20.6%
2,8340.0%0.02%
+25.0%
Q4 2017$388,000
+27.6%
2,834
+26.9%
0.02%
+14.3%
Q3 2017$304,000
+39.4%
2,234
+24.2%
0.01%
+27.3%
Q2 2017$218,000
+129.5%
1,798
+99.8%
0.01%
+120.0%
Q1 2017$95,000
+17.3%
900
+12.5%
0.01%0.0%
Q4 2016$81,000
-1.2%
8000.0%0.01%0.0%
Q3 2016$82,000
-86.5%
800
-94.8%
0.01%
-50.0%
Q2 2016$608,000
+78.8%
15,312
+383.3%
0.01%
+100.0%
Q1 2016$340,000
-12.8%
3,168
-12.0%
0.01%
-16.7%
Q4 2015$390,000
+314.9%
3,600
+227.3%
0.01%
+500.0%
Q3 2015$94,0001,1000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders